Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily A Largent

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
The American Journal of Bioethics : AJOB|June 24, 2024
Fairly Incorporating Vaccination Status into Scarce Resource Allocation FrameworksGovind Persad, Emily A Largent
JAMA Neurology|March 12, 2019
Preclinical Alzheimer Disease and the Dawn of the Pre-CaregiverEmily A Largent, Jason Karlawish
JAMA Health Forum|October 11, 2022
COVID-19 Vaccine Refusal and Fair Allocation of Scarce Medical ResourcesGovind Persad, Emily A Largent
The Hastings Center Report|February 21, 2024
What Makes a Better Life for People Facing Dementia? Toward Dementia-Friendly Health and Social Policy, Medical Care, and Community Support in the United StatesBarak Gaster, Emily A Largent
JAMA Neurology|February 4, 2020
Rescuing Research Participants After Alzheimer Trials Stop Early: Sending Out an SOSEmily A Largent, Jason Karlawish
The Hastings Center Report|May 24, 2012
Which orphans will find a home? The rule of rescue in resource allocation for rare diseasesEmily A Largent, Steven D Pearson
Journal of Medical Ethics|October 14, 2020
Compensating for research risk: permissible but not obligatoryHolly Fernandez Lynch, Emily A Largent
JAMA Neurology|February 19, 2024
Diagnosing Preclinical and Prodromal Neurodegenerative Diseases-The Clinical Is PoliticalClaire M Erickson, Emily A Largent
Clinical Trials (London, England)|December 21, 2018
Making the case for completion bonuses in clinical trialsEmily A Largent, Holly Fernandez Lynch
JAMA Neurology|January 4, 2022
Bringing Alzheimer Disease Testing and Results Disclosure Into the 21st Century Cures ActEmily A Largent, Angela R Bradbury
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
The American Journal of Bioethics : AJOB|June 24, 2024
Fairly Incorporating Vaccination Status into Scarce Resource Allocation FrameworksGovind Persad, Emily A Largent
JAMA Neurology|March 12, 2019
Preclinical Alzheimer Disease and the Dawn of the Pre-CaregiverEmily A Largent, Jason Karlawish
JAMA Health Forum|October 11, 2022
COVID-19 Vaccine Refusal and Fair Allocation of Scarce Medical ResourcesGovind Persad, Emily A Largent
The Hastings Center Report|February 21, 2024
What Makes a Better Life for People Facing Dementia? Toward Dementia-Friendly Health and Social Policy, Medical Care, and Community Support in the United StatesBarak Gaster, Emily A Largent
JAMA Neurology|February 4, 2020
Rescuing Research Participants After Alzheimer Trials Stop Early: Sending Out an SOSEmily A Largent, Jason Karlawish
The Hastings Center Report|May 24, 2012
Which orphans will find a home? The rule of rescue in resource allocation for rare diseasesEmily A Largent, Steven D Pearson
Journal of Medical Ethics|October 14, 2020
Compensating for research risk: permissible but not obligatoryHolly Fernandez Lynch, Emily A Largent
JAMA Neurology|February 19, 2024
Diagnosing Preclinical and Prodromal Neurodegenerative Diseases-The Clinical Is PoliticalClaire M Erickson, Emily A Largent
Clinical Trials (London, England)|December 21, 2018
Making the case for completion bonuses in clinical trialsEmily A Largent, Holly Fernandez Lynch
JAMA Neurology|January 4, 2022
Bringing Alzheimer Disease Testing and Results Disclosure Into the 21st Century Cures ActEmily A Largent, Angela R Bradbury
Pageof 14